• Applikationsbericht

Verapamil

Verapamil

  • Waters Corporation

This is an Application Brief and does not contain a detailed Experimental section.

Abstract

This application brief demonstrates analysis of verapamil.

Introduction

The compound analyzed in this study is verapamil.

USP Tailing Factor

  1. 1.27

Experimental

HPLC Method

Column:

Symmetry C8, 3.9 x 150 mm, 5 μm

Guard Column:

Sentry Guard Column 3.9 x 20mm, 5 μm

Part numbers:

Column - WAT046970, Guard - WAT054250

Mobile phase:

10 mM sodium acetate with 3.3% glacial acetic acid, pH 2.6/acetonitrile 70:30

Flow rate:

1.0 mL/min

Injection volume:

10 μL of 100 μg/mL sample

Detection:

UV @ 278 nm

Results and Discussion

Featured Products

WA31763.177, June 2003

Zurück zum Seitenanfang Zurück zum Seitenanfang